Yingying Mao, Ph.D.
Affiliations: | 2009 | Physiology | Temple University, Philadelphia, PA, United States |
Area:
Physiology BiologyGoogle:
"Yingying Mao"Mean distance: (not calculated yet)
Parents
Sign in to add mentorSatya P. Kunapuli | grad student | 2009 | Temple University | |
(Role of protease-activated receptors in platelet activation.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zheng L, Mao Y, Abdelgawwad MS, et al. (2016) Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura. Blood Advances. 1: 75-83 |
Pickens B, Mao Y, Li D, et al. (2015) Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models. Blood. 125: 3326-34 |
Bao J, Xiao J, Mao Y, et al. (2014) Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 397-407 |
Mao Y, Kunapuli SP. (2013) Trypsin causes platelet activation independently of known protease-activated receptors. Thrombosis and Haemostasis. 110: 1241-9 |
Getz TM, Manne BK, Buitrago L, et al. (2013) Dextran sulphate induces fibrinogen receptor activation through a novel Syk-independent PI-3 kinase-mediated tyrosine kinase pathway in platelets. Thrombosis and Haemostasis. 109: 1131-40 |
Pickens B, Mao Y, Zheng XL. (2013) ADAMTS13 Expressed In Platelets Offers Systemic Protection Against Arterial Thrombosis and Therapeutic Benefits In Murine Models Of Thrombotic Thrombocytopenic Purpura Blood. 122: 446-446 |
Bao J, Mao Y, Zheng XL. (2013) Carboxyl Terminal Domains Of ADAMTS13 Inhibit The Formation Of Ultra Large VWF Strings and Platelet/Leukocyte Aggregates On Endothelial Cells In Murine Mesenteric Venules Via a Disulfide Bond Reduction Mechanism Blood. 122: 445-445 |
Mao Y, Zhang L, Jin J, et al. (2010) Mutational analysis of residues important for ligand interaction with the human P2Y(12) receptor. European Journal of Pharmacology. 644: 10-6 |
Mao Y, Zhang M, Tuma RF, et al. (2010) Deficiency of PAR4 attenuates cerebral ischemia/reperfusion injury in mice. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 1044-52 |
Mao Y, Jin J, Daniel JL, et al. (2009) Regulation of plasmin-induced protease-activated receptor 4 activation in platelets. Platelets. 20: 191-8 |